1. Home
  2. Companies
  3. CQT
  4. Material Events

Conneqt Health (ASX:CQT) — Material Events

ASX:CQT · 16 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 10 articles Notable 6 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
10
CONNEQT Health Hits $7M Pulse Revenue Run-Rate Amid Tight Cash PositionMedium
CONNEQT Health reports record Pulse sales, $7M annualised revenue run-rate, and secures $1.1M R&D funding
28 Apr 2026 ·Quarterly Business Update ·85
CONNEQT Health Scales Consumer Revenue and Enterprise Subscriptions Amid FDA Software PushMedium
CONNEQT Health delivers record consumer revenue, 70% enterprise subscription growth, and advances FDA regulatory pathway
21 July 2026 ·Quarterly Business Update ·85
CONNEQT Advances FDA Pathway for Cloud-Based Cardiovascular AnalyticsMedium
CONNEQT lodges FDA Pre-Submission for SphygmoCor Cloud SaMD platform
23 June 2026 ·Regulatory Filing ·85
CONNEQT Health Accelerates Growth with Pulse Sales Surge and New Pricing ModelMedium
CONNEQT Health reports strong Pulse sales growth, new pricing model, US clinical trial contract, and cost reductions
30 Oct 2025 ·Quarterly Activities Report ·85
CONNEQT Health’s Pulse Sales Soar 200% as Recurring Revenue Model Gains TractionMedium
CONNEQT Health Q2 FY26 Pulse sales surge 200%, advances recurring revenue model with new enterprise contracts
30 Jan 2026 ·Quarterly Activities and Cashflow Report ·85
CONNEQT Health Secures A$5.5 Million Placement to Boost Pulse GrowthMedium
CONNEQT Health raises A$5.5 million placement to fuel commercial growth and launches Share Purchase Plan
19 June 2026 ·Capital Raising ·85
CONNEQT Health Accelerates Revenue Growth Amid Strategic Shift to Recurring ModelsMedium
CONNEQT Health reports 40% revenue growth, narrows net loss, advances recurring revenue model
27 Feb 2026 ·Appendix 4D and Half Year Financial Report ·75
CONNEQT Health Secures $1.1M US Clinical Trial Contract for Cardiovascular TechMedium
CONNEQT Health wins US Phase 2b clinical trial contract worth A$1.1 million
28 Oct 2025 ·Major Contract Announcement ·75
CONNEQT Pulse Sales Surge Over 200% in December QuarterMedium
CONNEQT Pulse Sales Surpass Expectations with Over 200% Growth in December Quarter
16 Dec 2025 ·Sales Update ·75
CONNEQT Health Secures $3.1M to Accelerate Pulse Sales ExpansionMedium
CONNEQT Health Raises $3.1M via Institutional Placement to Boost Pulse Sales
22 Dec 2025 ·Capital Raising ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.